CLINICAL_TRIALS trial_result · 2020-10-12

Clinical Trial Update: Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment [Phase 3]

Phase 3 trial evaluating safety of QAW039 in asthma patients inadequately controlled on standard therapy; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: TERMINATED | Results posted: 2020-10-12